Inventor · disambiguated record
Anthony Quinn
Also filed as: QUINN ANTHONY · QUINN ANTHONY G
18 granted patents·17 pending applications·63 citations·filing 2006–2024
92Inventor score
Top patents by PatentIndex Score
35 records- 0194US8846603B2NPP1 fusion proteinsQUINN ANTHONY·Filed 2011·Granted Sep 30, 2014·26 cites·19 claims
- 0294US8663631B2Methods for treating lysosomal acid lipase deficiency in patientsQUINN ANTHONY·Filed 2011·Granted Mar 4, 2014·15 cites·32 claims
- 0390US10166274B2Methods for treating lysosomal acid lipase deficiency in patientsSYNAGEVA BIOPHARMA CORP·Filed 2015·Granted Jan 1, 2019·3 cites·7 claims
- 0487US2025025538A1Methods for treating lysosomal acid lipase deficiency in patientsALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 0585US11400141B2Methods for treating lysosomal acid lipase deficiency in patientsALEXION PHARMA INC·Filed 2018·Granted Aug 2, 2022·1 cites·10 claims
- 0684US10407671B2Lysosomal storage disease enzymesALEXION PHARMA INC·Filed 2017·Granted Sep 10, 2019·3 cites·20 claims
- 0783US10493135B2Methods of treating tissue calcificationALEXION PHARMA INC·Filed 2015·Granted Dec 3, 2019·4 cites·20 claims
- 0883US9540621B2NPP1 fusion proteinsSYNAGEVA BIOPHARMA CORP·Filed 2014·Granted Jan 10, 2017·4 cites·16 claims
- 0982US12076376B2Methods for treating lysosomal acid lipase deficiency in patientsALEXION PHARMA INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
- 1082US11717562B2Method and composition for treating arginase 1 deficiencyAERASE INC·Filed 2018·Granted Aug 8, 2023·2 cites·46 claims
- 1180US2023129977A1Npp1 fusion proteinsINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1274US11560554B2Lysosomal storage disease enzymesALEXION PHARMA INC·Filed 2020·Granted Jan 24, 2023·0 cites·13 claims
- 1374US11007256B2Synthetic lipopeptide vaccines and immunotherapeuticsUNIV TOLEDO·Filed 2017·Granted May 18, 2021·2 cites·20 claims
- 1474US10858638B2Lysosomal storage disease enzymesALEXION PHARMA INC·Filed 2019·Granted Dec 8, 2020·0 cites·20 claims
- 1573US9579366B2Recombinant human NaGlu protein and uses thereofSYNAGEVA BIOPHARMA CORP·Filed 2012·Granted Feb 28, 2017·2 cites·18 claims
- 1673US2021301268A1Npp1 fusion proteinsINOZYME PHARMA INC·Filed 2020·Application pending·0 cites
- 1769US10557161B2Recombinant human ADA2 and ADA2 fusion proteins and methods for treating ADA2 deficienciesALEXION PHARMA INC·Filed 2015·Granted Feb 11, 2020·1 cites·17 claims
- 1869US2014348752A1Methods for treating lysosomal acid lipase deficiency in patientsSYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 1968US2024009284A1Method and composition for treating arginase 1 deficiencyAERASE INC·Filed 2023·Application pending·0 cites
- 2065US2015024460A1Npp1 fusion proteinsSYNAGEVA BIOPHARMA CORP·Filed 2014·Application pending·0 cites
- 2162US2017145393A1Npp1 fusion proteinsALEXION PHARMA INC·Filed 2017·Application pending·0 cites
- 2261US12144848B2Arginine depletion therapy for treatment of GAMT deficiencyAERASE INC·Filed 2019·Granted Nov 19, 2024·0 cites·35 claims
- 2360US2025228921A1Treatment of arginase 1 deficiencyIMMEDICA PHARMA AB·Filed 2023·Application pending·0 cites
- 2457US2014154774A1Npp1 fusion proteinsQUINN ANTHONY·Filed 2011·Application pending·0 cites
- 2554US2013209436A1Lysosomal storage disease enzymesQUINN ANTHONY·Filed 2011·Application pending·0 cites
- 2649US7994279B2Altered peptide ligands of GAD65UNIV TOLEDO·Filed 2007·Granted Aug 9, 2011·0 cites·3 claims
- 2747US2010312732A1Methods and systems for response detection and efficacyRoche Palo Alto·Filed 2010·Application pending·0 cites
- 2846USRE49529EMethods of treating tissue calcificationINOZYME PHARMA INC·Filed 2015·Granted May 16, 2023·0 cites·29 claims
- 2946US2017266264A1Truncated lysosomal acid lipaseALEXION PHARMA LLC·Filed 2016·Application pending·0 cites
- 3045US2017216412A1Recombinant human naglu protein and uses thereofALEXION PHARMA INC·Filed 2017·Application pending·0 cites
- 3145US2015098933A1Truncated lysosomal acid lipaseSYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 3244US2015030582A1Lysosomal Storage Disease EnzymeHARVEY ALEX J·Filed 2014·Application pending·0 cites
- 3343US2008120570A1Methods for managing windows within an internet environment and systems thereofBLUETIE INC·Filed 2006·Application pending·0 cites
- 3435US2020038491A1Methods for reducing liver fibrosis and treating lysosomal acid lipase deficiency in patients based on ishak fibrosis stageALEXION PHARMA INC·Filed 2017·Application pending·0 cites
- 3529US10413597B2Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)ALEXION PHARMA INC·Filed 2015·Granted Sep 17, 2019·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Anthony Quinn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →